Efficacy of Isolated Whey and Micellar Whey Protein (+/-Citrulline) to Stimulate Protein Synthesis in 'Healthy' and 'Anabolically Resistant' Elderly Muscle
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Older Adults
- Sponsor
- McMaster University
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Myofibrillar fractional synthetic rate will be measured using 13C6 ring phenylalanine
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
As the loss of muscle mass with aging is associated with a dysregulation of muscle protein synthesis (MPS) that is generally characterized by an 'anabolic resistance' to nutrients, the primary outcome of the trial is to investigate the effect of a mixed macronutrient beverage on post-prandial myofibrillar MPS. However, the 'anabolic resistance' of aging may be predominantly influenced by the contractile activity of skeletal muscle; for example, the investigators have demonstrated that 2 weeks of reduced habitual activity (i.e. daily step count) induces anabolic resistance in otherwise healthy older adults. In contrast, resistance exercise is well-known to enhance muscle mass and can increase the sensitivity of skeletal muscle to dietary amino acids. Therefore, all participants will undergo a 2-week reduced step count intervention combined with a unilateral leg resistance exercise protocol to induce an 'unhealthy' or 'anabolically resistant' leg and a relatively 'healthy' or 'anabolically sensitive' leg, respectively; this within subject model will be utilized to investigate the effect of the mixed macronutrient beverage in both relatively 'healthy' and 'unhealthy' older muscle. The investigators will also measure changes in muscle mass, muscle function, and cardiovascular health of both legs before and after the 2-week intervention to determine the effect of reduced activity and the protective effect of minimal, low-intensity exercise on these outcomes.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Non-smoker
Exclusion Criteria
- •Health problems such as: heart disease, rheumatoid arthritis, diabetes, poor lung function, uncontrolled hypertension, or any health conditions that might put the participant at risk for this study
- •Failed clearance for exercise participation by the participants family physician/medical doctor
- •Failed an exercise strength test.
- •Regular consumption of any analgesic or anti-inflammatory drug(s), prescription or non-prescription, chronically will be excluded.
- •Taking any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
- •Factors that may exclude a participant from an MRI scan (i.e. various implants, metal in the eyes etc)
- •Participants who complete fewer than 5000 steps per day (as assessed by pedometer prior to the study).
Outcomes
Primary Outcomes
Myofibrillar fractional synthetic rate will be measured using 13C6 ring phenylalanine
Time Frame: 7 hours
analysis
Secondary Outcomes
- body composition (lean body mass, fat mass, leg lean mass, leg fat mass) will be measured using dual energy xray absorptiometry(14 days)
- leg muscle strength (leg press and leg extension 1 repetition maximum [1-RM], peak knee extensor torque) will be measured using a dynamometer(14 days)
- vascular function (femoral blood flow, femoral artery diameter, leg pulse) will be measured using doppler ultrasound(14 days)